Sensyne Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sensyne Health generated cash of -$25,069,000, which is less than the previous year. Cash used in financing activities reached the amount of $25,100,000 last year. Net change in cash is therefore -$8,083,000.
Cash Flow
| 2018 | -5.37M | -594K | 10.50M |
|---|---|---|---|
| 2020 | -14.65M | -2.71M | -267K |
| 2021 | -25.06M | -8.17M | 25.1M |
SENS.L Cash Flow Statement (2017 – 2020)
| 2020 | 2019 | 2017 | |
|---|---|---|---|
Cash at beginning of period | 31.65M | 49.25M | 0 |
Operating activities | |||
Net income | -27.52M | -21.83M | -7.07M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 5.74M | 4.79M | 1.03M |
Stock-based compensation expense | 846K | 235K | 0 |
| Deferred income tax benefit | 846K | 235K | 0 |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 |
Cash generated by operating activities | -25.06M | -14.65M | -5.37M |
Investing activities | |||
Purchases Of Investments | -2.32M | -556K | 0 |
Investments In Property Plant And Equipment | -5.84M | -2.16M | -594K |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -8.17M | -2.71M | -594K |
Financing activities | |||
Common Stock Issued | 27.46M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 |
Cash used in financing activities | 25.1M | -267K | 10.50M |
Net Change In Cash | -8.08M | -17.59M | 4.54M |
Cash at end of period | 23.57M | 31.65M | 4.54M |
| Data source | Data source | Data source |